| CLLS2 |
|
Disrupted in B-cell neoplasia
|
|
|
0.678 |
0.346 |
| CD52 |
P31358
|
CD52 molecule
|
|
0.40 |
0.615 |
0.500 |
| TCL1A |
P56279
|
T cell leukemia/lymphoma 1A
|
|
5.7E-10 |
0.558 |
0.500 |
| TCL1B |
O95988
|
T cell leukemia/lymphoma 1B
|
|
1.0E-02 |
0.561 |
0.500 |
| CLEC4D |
Q8WXI8
|
C-type lectin domain family 4 member D
|
|
2.5E-06 |
0.587 |
0.538 |
| CD79B |
P40259
|
CD79b molecule
|
Receptor
|
0.92 |
0.576 |
0.577 |
| LOC390714 |
|
immunoglobulin heavy chain variable region
|
|
|
0.617 |
0.615 |
| LOC105379528 |
|
uncharacterized LOC105379528
|
|
|
0.617 |
0.615 |
| IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
| PAX5 |
Q02548
|
paired box 5
|
|
1.00 |
0.487 |
0.654 |
| IGHV3OR16-7 |
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene)
|
|
|
0.566 |
0.654 |
| IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |
| LAIR1 |
Q6GTX8
|
leukocyte associated immunoglobulin like receptor 1
|
Receptor
|
3.3E-07 |
0.569 |
0.692 |
| BCL3 |
P20749
|
BCL3 transcription coactivator
|
|
0.99 |
0.541 |
0.731 |
| TRAF1 |
Q13077
|
TNF receptor associated factor 1
|
Signaling
|
3.6E-03 |
0.554 |
0.731 |
| BCL2L11 |
O43521
|
BCL2 like 11
|
|
0.89 |
0.510 |
0.731 |
| TNFSF13B |
Q9Y275
|
TNF superfamily member 13b
|
|
0.98 |
0.460 |
0.731 |
| ICOS |
Q9Y6W8
|
inducible T cell costimulator
|
|
3.1E-02 |
0.502 |
0.731 |
| MARCKSL1 |
P49006
|
MARCKS like 1
|
|
1.4E-02 |
0.508 |
0.731 |
| WLS |
Q5T9L3
|
Wnt ligand secretion mediator
|
|
2.0E-02 |
0.513 |
0.731 |
| TNFRSF13C |
Q96RJ3
|
TNF receptor superfamily member 13C
|
|
0.27 |
0.540 |
0.731 |
| ANG |
P03950
|
angiogenin
|
|
0.29 |
0.511 |
0.769 |
| CXCR5 |
P32302
|
C-X-C motif chemokine receptor 5
|
G-protein coupled receptor
|
0.73 |
0.524 |
0.769 |
| CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
| CCR7 |
P32248
|
C-C motif chemokine receptor 7
|
G-protein coupled receptor
|
5.8E-02 |
0.443 |
0.769 |